Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.

MLA

Ortega-Villa, Ana M., et al. “Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.” Open Forum Infectious Diseases, vol. 10, no. 6, May 2023, p. ofad290. EBSCOhost, https://doi.org/10.1093/ofid/ofad290.

APA

Ortega-Villa, A. M., Hynes, N. A., Levine, C. B., Yang, K., Wiley, Z., Jilg, N., Wang, J., Whitaker, J. A., Colombo, C. J., Nayak, S. U., Kim, H. J., Iovine, N. M., Ince, D., Cohen, S. H., Langer, A. J., Wortham, J. M., Atmar, R. L., El Sahly, H. M., Jain, M. K., … Tomashek, K. M. (2023). Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case. Open Forum Infectious Diseases, 10(6), ofad290. https://doi.org/10.1093/ofid/ofad290

Chicago

Ortega-Villa, Ana M, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, Jing Wang, et al. 2023. “Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.” Open Forum Infectious Diseases 10 (6): ofad290. doi:10.1093/ofid/ofad290.